The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy

Cancer

Volumn 88, Issue 5, 2000, Pages 1072-1077

  Abner, Anthony L ^a,c   Connolly, James L ^a   Recht, Abram ^a   Bornstein, Bruce ^a,b   Nixon, Asa ^a   Hetelekidis, Stella ^a,b   Silver, Barbara ^a   Harris, Jay R ^a,b   Schnitt, Stuart J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

Breast carcinoma; Conservative surgery; Lobular carcinoma in situ; Local recurrence; Radiation therapy

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0034162506     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1072::AID-CNCR18>3.0.CO;2-D     Document Type: Article

References (22)

1. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, et al. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
2. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991;338:327-31.
3. Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996;78:1921-8.
4. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:1356-61.
5. Kurtz JM, Jacquemier J, Amalric R. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990;65:1867-78.
6. Clarke DH, Le MG, Sarrazin D. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985;11:137-45.
7. Nixon, AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-94.
8. Vicini FA, Eberlein TJ, Connolly JL, Recht A, Abner A, Schnitt SJ, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991;214:200-4; discussion, 204-5.
9. Foote F, Stewart F. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941;17:491-6.
10. Andersen JA. Lobular carcinoma in situ of the breast: an approach to rational treatment. Cancer 1977;39:2597-602.
11. Rosen P, Lieberman P, Braun D. Lobular carcinoma in situ of the breast. Am J Surg Pathol 1978;2:225-51.
12. Morris DM, Walker AP, Coker DC. Lack of efficacy of xeromammography in preoperatively detecting lobular carcinoma in situ of the breast. Breast Cancer Res Treat 1982;1:363.
13. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-69.
14. Morrow M, Schnitt S. Lobular carcinoma in situ. In: Harris JR, Morrow M, Lippman M, Hellman S, editors. Diseases of the breast. New York: Lippincott-Raven, 1996:369-74.
15. Azzopardi JG, Chepick OF, Hartman WF, et al. The World Health Organization histological typing of breast tumors. 2nd edition. Am J Clin Pathol 1982;78:806-16.
16. Siddon RL, Buck BA, Harris JR, Svensson GK. Three-field technique for breast irradiation using tangential field corner blocks. Int J Radiat Oncol Biol Phys 1983;9:583-8.
17. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence. J Clin Oncol 1990;8:548-55.
18. Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer 1996;78:1403-16.
19. Moran M, Haffty BG. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys 1998;40:353-8.
20. Griem K, Hartsell D, Recine M, et al. What is the significance of a lobular carcinoma in situ component in women treated with breast conserving therapy for early stage breast cancer? Int J Radiat Oncol Biol Phys 1993;27(Suppl):269.
21. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90:1371-88.
22. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999; 353:1993-2000.